GBA's "2021 Stock Phantasma"

THE WARNING A LA GREENSPAN....

  • Quote:"Vulnerabilities associated with elevated risk appetite are rising," added Fed Governor Lael Brainard in an accompanying statement. Stock prices are high compared with earnings, and "the appetite for risk has increased broadly, as the 'meme stock' episode demonstrated." Fed Chairman Jerome Powell also described parts of the market as "a bit frothy" last week. "I won't say it has nothing to do with monetary policy, but it also has a tremendous amount to do with vaccination and reopening of the economy."
 
Orgenesis posts four-fold revenue growth in Q1, shares rise 11%
  • Orgenesis(NASDAQ:ORGS) jumps 11% premarket after announcing financial results for the first quarter ended March 31, 2021.
  • The company reported Q1 total revenues of $9.4M, an increase of 400% over prior year.
  • ORGS achieved positive operating profit of $0.08M for Q1 vs. operating loss of $6.7M in same period prior year.
  • Net loss for Q1 narrowed to $0.3M or ($0.01) per share compared to loss of $7M or ($0.39) per share in Q1 2020.
  • Cash and cash equivalents as of March 31 were of $41.8M compared to $44.9M at the end of December 31, 2020.
  • “Our first quarter results illustrate the potential of our new POCare strategy, as evidenced by more than a four-fold increase in revenue for the first quarter of 2021. This growth is a direct result of long-term contracts with our regional partners as they work to advance our therapeutic pipeline and scale production capabilities in their respective territories," stated Vered Caplan, CEO.
  • Recently, FDA OK'd Orgenesis IDE for its clinical trial of Tissue Genesis Icellator2 to treat ARDS due to COVID-19.
 
Still fuming I missed this by 24 hrs... Was reading the wrong day's earnings dates and got confused....

WW International, Inc. (WW)

34.73+7.15 (+25.92%)<---------
 
Back when the chicken sandwich was being introduced at a major chain to compete with the Popey's success,,, I suggested buying into Chicken. I could get no support here nor at the Hedge Fund.... well now we are seeing " inflation in all parts of the bird."

Restaurant chains, before the pandemic, were able to purchase chicken at roughly $1.30 a pound, according to Rikhter. "But they're starting to see prices that are two to $2.20 a pound instead," he said.

Wingstop Chief Financial Officer Michael Skipworth recently told Yahoo Finance the chain saw prices for bone-in wings rise 25.8%last quarter but that was lower than the 50% competing chains were paying. "You're actually seeing inflation in all parts of the bird, not just wings," Skipworth said.

Not sure what the investment is other than to raise your own chickens!~
 
IS SHE THE PROBLEM?


Cathie Wood’s ARK Innovation ETF Is Selling Off—and It May Get Worse
f04df886b39b445a8382061fac0d5ddb

Cathie Wood’s ARK Innovation ETF Is Selling Off—and It May Get Worse
Is Cathie becoming the Wicked Witch Of stocks.
 
Sometimes I wish I had just married a rich dude. It's so easy that way.
It’s official: Melinda Gates is a billionaire after a nearly $2.4 billion stock transfer
e1cf00025bce51107655b5e8c22924ee

It’s official: Melinda Gates is a billionaire after a nearly $2.4 billion stock transfer
 


Cathie Wood’s ARK Innovation exchange-traded fund is significantly oversold and due for a bounce, but if it doesn’t get one the popular fund risks suffering a steeper decline that could spell some trouble for the broader market, says one chart watcher.

“With the big down day yesterday, ARKK actually violated a trendline that connected some notable lows going back to September, which isn’t ideal,” said technical analyst Andrew Adams, in a note for Saut Strategy on Wednesday. “It now
needs to recover this line quickly or risk breaking down in a possible waterfall decline.” (See chart below)

im-334408

SAUT STRATEGY
 
10 year yield sinks!!!

JOBS REPORT IS HORRIBLE BUT THAT'S GOOD! Remember Good news of a hyper growth economy was starting to be viewed negatively by the market...

I wonder if this isn't good somehow for stocks. And for refinancing.
 
vanzandt said:
Stoney....

If there's one thing I've learned over the years, there can be many reasons for an insider to sell their stock; houses, wives, medical bills, drugs, gambling... lots of reasons that in no way reflect negatively on the material condition of the company in question.

But there's only one reason they buy their stock.

They are expecting it to go up.

Those are substantial insider buys. I had to dig deeper and I now know more about dry eye disease than most.

I looked up a lot of big words, I got on Wiki, I got on the FDA's site. The top treatment for this stuff is called Xiidra (lifitegrast). I looked at its history. Small bio-tech, bought by Shire, who got bought by Takeda. Shire owned it when it got FDA approval. The stock jumped 5%, but they were a huge company.
Here's the news:

https://www.investors.com/news/tech...-as-eye-drug-wins-early-approval-broad-label/

The drug's annual sales at the time were forecast to be north of a billion/year.

But the story gets even better... in 2019 Novartis bought Xiidra from Takeda for (and get this)... $5.3 Billion!
This news:

https://eyewire.news/articles/novar...on-of-xiidra-bolstering-ophthalmic-portfolio/

For one drug!

ALDX is a tiny biotech Stoney.
And they are in phase III with great results.
This drug works better than anything out there, and its gonna get approved.

Now we know why there has been $46 million dollars of insider buys in the last 12 months.

Kinda brings "tears to your eyes" eh Stoney?

It closed at $12.05
Buy it Stoney.
$ALDX
$12
-vz

Pretty sure I just earned a high 6 figure Xmas bonus from Gummy Bear Advisors.
More...


I don't know if I'm just Covid focused but the most interesting thing to me is one and maybe two of this companies programs seem to affect the bodies Cycline storm the over heated response to the Covid that results in the body attacking itself. <----

Right now at the FDA there is a HUGE LOGJAM and at least seven major programs for unmet needs have gone by he wayside as the FDA is so Covid-focused. New OK's are not happening.
Biotech is suffering because of this.

Just getting front of the FDA is becoming a victory in itself.
 
You must log in or register to reply here.
Back
Top